CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma

BACKGROUND: Comparative genetic and biological studies on malignant tumor counterparts in human beings and laboratory mice may be powerful gene discovery tools for blood cancers, including neoplasms of mature B-lymphocytes and plasma cells such as Burkitt lymphoma (BL) and multiple myeloma (MM). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seong-Su, Tompkins, Van S, Son, Dong-Ju, Han, Sangwoo, Yun, Hwakyung, Kamberos, Natalie L, Dehoedt, Casey L, Gu, Chunyan, Holman, Carol, Tricot, Guido, Zhan, Fenghuang, Janz, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383050/
https://www.ncbi.nlm.nih.gov/pubmed/25838973
http://dx.doi.org/10.1186/s40164-015-0005-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383050/
https://www.ncbi.nlm.nih.gov/pubmed/25838973
http://dx.doi.org/10.1186/s40164-015-0005-2

Ejemplares similares